Up a level |
Number of items: 1.
Schwartz, Gregory G, Szarek, Michael, Bittner, Vera A, Diaz, Rafael, Goodman, Shaun G, Jukema, J Wouter, Landmesser, Ulf, López-Jaramillo, Patricio, Manvelian, Garen, Pordy, Robert et al (show 5 more authors)
(2021)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Journal of the American College of Cardiology, 78 (5).
pp. 421-433.